Women who take aspirin everyday could lower their chances of developing ovarian cancer.
New research from the National Cancer Institute suggests a low dosage of aspirin ingested daily could curb risks of ovarian cancer in later life, according to a report by RTT News.
In the study, which was published in the journal of the national Cancer Institute, about 20,000 women were observed and interviewed.
8,000 of those women had ovarian cancer, while 12,000 did not.
A team of researchers discovered that the subjects who took a slight amount of aspirin each morning cut their risk of developing this specific kind of cancer by 20 percent in comparison to the women who took aspirin more sparingly.
The latter group took aspirin less than once a week, RTT reported.
Lead author of the study Britton Trabert acknowledged that the use of acetaminophen, commonly found in Tylenol, had no beneficial link with increased vitality.
This detail indicates there might not be a connection between better health and non-NSAID drugs like aspirin.
"Additional studies are needed to explore the delicate balance of risk-benefit for this potential chemopreventive agent, as well as studies to identify the mechanism by which aspirin may reduce ovarian cancer risk," Trabert wrote in the study's conclusion.
